Cancer is a genetic disease.
When actress Angelina Jolie went notable about her preventing double mastectomy, it did not leading to an increased understanding of the genetic risk of titty cancer, researchers say. Although it raised awareness of knocker cancer, exposure to Jolie's story may have resulted in greater discomfiture about the link between a family history of breast cancer and increased cancer risk, according to the study, published Dec 19, 2013 in the record book Genetics in Medicine where to buy vimax in gauteng. Earlier this year, Jolie revealed that she had both breasts removed after scholarship that she carried a altering in a gene called BRCA1 that is linked to heart of hearts and ovarian cancers.
Women with mutations in that gene and the BRCA2 gene have a five times higher endanger of boob cancer and a 10 to 30 times higher jeopardy of developing ovarian cancer than those without the mutations. For the study, researchers surveyed more than 2500 Americans. About 75 percent were sensitive of Jolie's story, the investigators found. But fewer than 10 percent of the respondents could correctly riposte questions about the BRCA gene transfiguring that Jolie carries and the ordinary woman's gamble of developing breast cancer.
So "Ms Jolie's trim story was prominently featured throughout the media and was a chance to draft health communicators and educators to teach about the nuanced issues around genetic testing, jeopardize and preventive surgery," study principal author Dina Borzekowski, a research professor in the University of Maryland School of Public Health's office of behavior and community health, said in a university low-down release. However, it "feels identical to it was a missed opportunity to educate the public about a complex but superlative health situation".